Voclosporin
Published , updated
Unassigned
New Medicines
Voclera · Lupus nephritis - as an adjunct to use with mycophenolate
Information
Voclera
New molecular entity
Aurinia
Aurinia
Development and Regulatory status
Phase II Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials
Category
Calcineurin inhibitor
In 2001, prevalence of lupus nephritis was estimated at 4.4 per 100,000 UK population [1].
Lupus nephritis - as an adjunct to use with mycophenolate
Oral
Mild to moderate dry eye syndrome
Information
New formulation
Aurinia
Aurinia
Development and Regulatory status
None
None
Phase III clinical trials
Category
Aqueous, preservative free nanomicellar ophthalmic solution; topical calcineurin inhibitor type immunosuppressant
Dry eye syndrome is estimated to affect between 5% and 33% of the adult population worldwide . Dry eye syndrome is more common in people aged 50 years or older, in females and in those who have had refractive surgery [3].
Mild to moderate dry eye syndrome
Topical